Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis

Santo, Augusto H.; Souza, José Maria P.; Pinheiro, Celso E.; Souza, Deborah C. C.; Sato, Emilia I.
January 2010
BMC Public Health;2010, Vol. 10, p597
Academic Journal
Background: Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmune rheumatic diseases with high fatality rates. There have been few population-based mortality studies of dermatomyositis and polymyositis in the world, and none have been conducted in Brazil. The objective of the present study was to employ multiple-cause- of-death methodology in the analysis of trends in mortality related to dermatomyositis and polymyositis in the state of São Paulo, Brazil, between 1985 and 2007. Methods: We analyzed mortality data from the São Paulo State Data Analysis System, selecting all death certificates on which DM or PM was listed as a cause of death. The variables sex, age and underlying, associated or total mentions of causes of death were studied using mortality rates, proportions and historical trends. Statistical analysis were performed by chi-square and H Kruskal-Wallis tests, variance analysis and linear regression. A p value less than 0.05 was regarded as significant. Results: Over a 23-year period, there were 318 DM-related deaths and 316 PM-related deaths. Overall, DM/PM was designated as an underlying cause in 55.2% and as an associated cause in 44.8%; among 634 total deaths females accounted for 71.5%. During the study period, age- and gender-adjusted DM mortality rates did not change significantly, although PM as an underlying cause and total mentions of PM trended lower (p < 0.05). The mean ages at death were 47.76 ± 20.81 years for DM and 54.24 ± 17.94 years for PM (p = 0.0003). For DM/PM, respectively, as underlying causes, the principal associated causes of death were as follows: pneumonia (in 43.8%/ 33.5%); respiratory failure (in 34.4%/32.3%); interstitial pulmonary diseases and other pulmonary conditions (in 28.9%/17.6%); and septicemia (in 22.8%/15.9%). For DM/PM, respectively, as associated causes, the following were the principal underlying causes of death: respiratory disorders (in 28.3%/26.0%); circulatory disorders (in 17.4%/ 20.5%); neoplasms (in 16.7%/13.7%); infectious and parasitic diseases (in 11.6%/9.6%); and gastrointestinal disorders (in 8.0%/4.8%). Of the 318 DM-related deaths, 36 involved neoplasms, compared with 20 of the 316 PM-related deaths (p = 0.03). Conclusions: Our study using multiple cause of deaths found that DM/PM were identified as the underlying cause of death in only 55.2% of the deaths, indicating that both diseases were underestimated in the primary mortality statistics. We observed a predominance of deaths in women and in older individuals, as well as a trend toward stability in the mortality rates. We have confirmed that the risk of death is greater when either disease is accompanied by neoplasm, albeit to lesser degree in individuals with PM. The investigation of the underlying and associated causes of death related to DM/PM broaden the knowledge of the natural history of both diseases and could help integrate mortality data for use in the evaluation of control measures for DM/PM.


Related Articles

  • Dermatomyositis and Malignancy. Barnes, Barbara E. // Annals of Internal Medicine;Jan76, Vol. 84 Issue 1, p68 

    Presents a literature review on the incidence of cancer in patients with dermatomyositis. Age and sex distribution of dermatomyositis; Tumor site; Laboratory findings in dermatomyositis.

  • Juvenile Dermatomyositis: Recognition and Treatment. Reed, A.M.; Lopez, M. // Pediatric Drugs;2002, Vol. 4 Issue 5, p315 

    Juvenile dermatomyositis (JDM) is a multisystem disease characterized by acute and chronic lymphocytic inflammation of the skeletal muscle and skin. The disease is marked early in its course by the presence of a vasculopathy or vasculitis, and later by the development of calcinosis. Research has...

  • Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India. Singh, Surjit; Suri, Deepti; Aulakh, Roosy; Gupta, Anju; Rawat, Amit; Kumar, Rohit // Clinical Rheumatology;Nov2014, Vol. 33 Issue 11, p1675 

    Survival and outcomes have improved considerably among patients with juvenile dermatomyositis (JDM) in the west. However, mortality continues to be high in the developing world. There is paucity of literature on this aspect of JDM from developing countries. We reviewed case files of all patients...

  • Clinical Presentation and Evaluation of Dermatomyositis. Marvi, Umaima; Chung, Lorinda; Fiorentino, David F. // Indian Journal of Dermatology;Sep/Oct2012, Vol. 57 Issue 5, p375 

    Dermatomyositis (DM) is a chronic inflammatory disorder of the skin and muscles. Evidence supports that DM is an immune-mediated disease and 50-70% of patients have circulating myositis-specific auto-antibodies. Gene expression microarrays have demonstrated upregulation of interferon signaling...

  • TIF1γ-overexpressing, Highly Progressive Endometrial Carcinoma in a Patient with Dermatomyositis Positive for Malignancy-associated Anti-p155/140 Autoantibody. Akira Kasuya; Yasuhito Hamaguchi; Manabu Fujimoto; Yoshiki Tokura // Acta Dermato-Venereologica;2013, Vol. 93 Issue 6, p715 

    The article describes the case of a anti-p155/140 antibody- positive dermatomyositis in a 52-year-old woman which shows the coexistence of a transcriptional intermediary factor 1γ (TIF1γ)-overexpressing malignant neoplasm. She developed facial and palpebral oedema, erythema on the trunk,...

  • Acquired Reactive Perforating Collagenosis: A Rare Association with Dermatomyositis. Nobuyuki Kikuchi; Mikio Ohtsuka; Toshiyuki Yamamoto // Acta Dermato-Venereologica;2013, Vol. 93 Issue 6, p735 

    The article describes two cases of acquired reactive perforating collagenosis (ARPC) in patients with clinically amyopathic dermatomyositis. It cited the factors which triggered ARPC which include folliculitis, arthropod bites and scabies infection. It concluded that ARPC may be one of the rate...

  • Dermatomiyozit hastasında anestezik yaklaşım. Akçaboy, Zeynep Nur; Akçaboy, Erkan Yavuz; Bayrakçı, Sinem Yalçın; Soyal, Özlem; Göğüş, Nermin // Journal of Clinical & Experimental Investigations / Klinik ve De;2012, Vol. 3 Issue 2, p277 

    Dermatomyositis is a rare disease of unknown etiology characterized by proximal muscle weakness as a result of inflammation and degeneration of muscles. Concerning the anesthetic management of a patient with dermatomyositis, there is little and conflict information on the appropriate use of...

  • Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study. Phillips, Beverley A.; Zilko, Paul J.; Garlepp, Michael J.; Mastaglia, Frank L. // Journal of Neurology;Apr2002, Vol. 249 Issue 4, p441 

    The seasonal occurrence of relapses was analysed retrospectively in a group of 53 patients with treated dermatomyositis (DM) or polymyositis (PM). In DM, the incidence of both myositic and cutaneous relapses was highest in summer whereas in the PM group relapses was more evenly distributed...

  • Juvenile dermatomyositis associated with lipodystrophy. Irene, N. T.; Parveen, B.; Hema, O. H.; Rajagopalan, V. // Indian Journal of Dermatology, Venereology & Leprology;Sep/Oct2003, Vol. 69 Issue 5, p343 

    Lipodystrophy and associated metabolic abnormalities are being increasingly recognized as complications of juvenile dermatomyositis. We report one such case.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics